Home › Funds › MONTANOVA CAPITAL, LLC › PROK

MONTANOVA CAPITAL, LLC position in PROK

PROKIDNEY CORP · Health Care

MONTANOVA CAPITAL, LLC reported holding 12,341,266 shares of PROK (PROKIDNEY CORP) in its Q2 2026 13F filing — a position valued at US$25.2M, representing 0.46% of its reported portfolio and ranking #48 among its reported holdings. MONTANOVA CAPITAL, LLC has disclosed PROK holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)12.34M sh
Reported value held$25.18M
Portfolio Weight0.46%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How MONTANOVA CAPITAL, LLC's PROK position evolved

MONTANOVA CAPITAL, LLC first disclosed a stake in PROK in Q3 2023 at 3,867,843 shares (US$17.7M). The position peaked in Q3 2025 at 12,341,266 shares, worth US$29.9M. Across 12 filings, MONTANOVA CAPITAL, LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 9 time(s). The most recent filing (Q2 2026) shows 12,341,266 shares valued at US$25.2M. Notable position changes include a 142% increase in Q2 2024 (shares fell 22% over the following quarter), a 32% increase in Q3 2024 (shares fell 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.87M $17.71M New
Q4 2023 3.87M $6.88M Hold
Q1 2024 3.87M $6.34M Hold
Q2 2024 9.34M $22.98M Add
Q3 2024 12.34M $23.70M Add
Q4 2024 12.34M $20.86M Hold
Q1 2025 12.34M $10.81M Hold
Q2 2025 12.34M $7.31M Hold
Q3 2025 12.34M $29.87M Hold
Q4 2025 12.34M $27.64M Hold
Q1 2026 12.34M $22.09M Hold
Q2 2026 12.34M $25.18M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PROK and 13F data

PROK (PROKIDNEY CORP) is a Health Care company. 37 other funds we track also report a position in PROK — the largest reported positions include Bleichroeder LP (US$4.1M), Artia Global Partners LP (US$3.7M), Brown University (US$2.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PROK

All PROK fund holders →

FAQ

How long has MONTANOVA CAPITAL, LLC held PROK?

MONTANOVA CAPITAL, LLC has disclosed PROK holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is MONTANOVA CAPITAL, LLC's current position in PROK?

As of Q2 2026, MONTANOVA CAPITAL, LLC holds 12.34M shares of PROK (PROKIDNEY CORP), valued at $25.18M, representing 0.46% of its reported portfolio and ranking #48.

Has MONTANOVA CAPITAL, LLC been buying or selling PROK?

In the latest 13F filing (Q2 2026), MONTANOVA CAPITAL, LLC held unchanged its position in PROK. The position peaked in Q3 2025 at 12.34M shares.

Which other funds hold PROK?

Other major institutional holders of PROK include Bleichroeder LP, Artia Global Partners LP, Brown University, among 37 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.